Mungo C, Adewumi K, Adoyo E, Zulu G, Goraya S, Ogollah C
Front Oncol. 2024; 14:1360337.
PMID: 38532929
PMC: 10964769.
DOI: 10.3389/fonc.2024.1360337.
Tatar B
Arch Gynecol Obstet. 2022; 308(1):183-191.
PMID: 36512112
DOI: 10.1007/s00404-022-06876-8.
Stanca M, Ciobanu V, Gheorghe M, Kiss S, Cozlea A, Capilna M
J Pers Med. 2021; 11(1).
PMID: 33466295
PMC: 7824800.
DOI: 10.3390/jpm11010029.
Ono A, Koshiyama M, Nakagawa M, Watanabe Y, Ikuta E, Seki K
Medicina (Kaunas). 2020; 56(11).
PMID: 33182663
PMC: 7698010.
DOI: 10.3390/medicina56110604.
Xie S, Pan S, Zou S, Zhu H, Zhu X
Clin Interv Aging. 2020; 15:841-851.
PMID: 32606624
PMC: 7293398.
DOI: 10.2147/CIA.S255305.
Fertility preservation in women affected by gynaecological cancer: the importance of an integrated gynaecological and psychological approach.
La Rosa V, Garzon S, Gullo G, Fichera M, Sisti G, Gallo P
Ecancermedicalscience. 2020; 14:1035.
PMID: 32419847
PMC: 7221134.
DOI: 10.3332/ecancer.2020.1035.
Serum exosomal microRNA-34a as a potential biomarker in epithelial ovarian cancer.
Maeda K, Sasaki H, Ueda S, Miyamoto S, Terada S, Konishi H
J Ovarian Res. 2020; 13(1):47.
PMID: 32336272
PMC: 7184688.
DOI: 10.1186/s13048-020-00648-1.
Evaluation of PCR-Reverse Dot Blot Human Papillomavirus Genotyping Test in Predicting Residual/Recurrent CIN 2+ in Posttreatment Patients in China.
Zhang Q, Dong B, Chen L, Lin T, Tong Y, Lin W
Cancer Manag Res. 2020; 12:2369-2379.
PMID: 32308477
PMC: 7132552.
DOI: 10.2147/CMAR.S237490.
Survival After Abdominal Q-M Type B versus C2 Radical Hysterectomy for Early-Stage Cervical Cancer.
Chen C, Wang W, Liu P, Li P, Wang L, Jin S
Cancer Manag Res. 2020; 11:10909-10919.
PMID: 32021416
PMC: 6955639.
DOI: 10.2147/CMAR.S220212.
Prediction of Structure and Molecular Interaction with DNA of BvrR, a Virulence-Associated Regulatory Protein of .
Ramirez-Gonzalez E, Moreno-Lafont M, Mendez-Tenorio A, Cancino-Diaz M, Estrada-Garcia I, Lopez-Santiago R
Molecules. 2019; 24(17).
PMID: 31470504
PMC: 6749498.
DOI: 10.3390/molecules24173137.
Evaluation of Neutrophil-Lymphocyte Ratio as a Prognostic Factor in Cervical Intraepithelial Neoplasia Recurrence.
Farzaneh F, Faghih N, Hosseini M, Arab M, Ashrafganjoei T, Bahman A
Asian Pac J Cancer Prev. 2019; 20(8):2365-2372.
PMID: 31450907
PMC: 6852826.
DOI: 10.31557/APJCP.2019.20.8.2365.
A preliminary cervical cancer screening cascade for eight provinces rural Chinese women: a descriptive analysis of cervical cancer screening cases in a 3-stage framework.
Wang S, Wu J, Zheng R, Xiong W, Chen J, Ma L
Chin Med J (Engl). 2019; 132(15):1773-1779.
PMID: 31335474
PMC: 6759122.
DOI: 10.1097/CM9.0000000000000353.
Clinical and Psychological Outcomes of the Use of Vaginal Dilators After Gynaecological Brachytherapy: a Randomized Clinical Trial.
Cerentini T, Schlottgen J, Da Rosa P, La Rosa V, Vitale S, Giampaolino P
Adv Ther. 2019; 36(8):1936-1949.
PMID: 31209699
PMC: 6822871.
DOI: 10.1007/s12325-019-01006-4.
Net survival of patients with colorectal cancer: a comparison of two periods.
Stor Z, Blagus R, Tropea A, Biondi A
Updates Surg. 2019; 71(4):687-694.
PMID: 31190323
DOI: 10.1007/s13304-019-00662-z.
Predictors of Absent High-grade Cervical Intraepithelial Neoplasia (CIN) in Loop Electrosurgical Excision Procedure Specimens of Patients with Colposcopic Directed Biopsy-Confirmed High-Grade CIN.
Poomtavorn Y, Tanprasertkul C, Sammor A, Suwannarurk K, Thaweekul Y
Asian Pac J Cancer Prev. 2019; 20(3):849-854.
PMID: 30912403
PMC: 6825759.
DOI: 10.31557/APJCP.2019.20.3.849.
The expression of special AT-rich binding protein 1 in cervical cancer and its clinical significance.
Zhao L, Zheng Y, Ji Y, Zhang X
Onco Targets Ther. 2019; 12:945-951.
PMID: 30774380
PMC: 6361226.
DOI: 10.2147/OTT.S191414.
Does Male Circumcision Reduce Women's Risk of Sexually Transmitted Infections, Cervical Cancer, and Associated Conditions?.
Morris B, Hankins C, Banerjee J, Lumbers E, Mindel A, Klausner J
Front Public Health. 2019; 7:4.
PMID: 30766863
PMC: 6365441.
DOI: 10.3389/fpubh.2019.00004.
Upregulated expression of serum exosomal miR-375 and miR-1307 enhance the diagnostic power of CA125 for ovarian cancer.
Ying Su Y, Sun L, Guo Z, Li J, Bai T, Cai X
J Ovarian Res. 2019; 12(1):6.
PMID: 30670062
PMC: 6341583.
DOI: 10.1186/s13048-018-0477-x.
Tumor markers of uterine cervical cancer: a new scenario to guide surgical practice?.
Valenti G, Vitale S, Tropea A, Biondi A, Lagana A
Updates Surg. 2017; 69(4):441-449.
PMID: 28918603
DOI: 10.1007/s13304-017-0491-3.